A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of a Nutritional Supplement (ImmuActive^TM) for COVID-19 Patients

Table 1

Composition of ImmuActive^TM.

S. no.	Ingredients	Label claim
1	C3 Reduct® ODN	100 mg
2	Andrographis paniculata extract >90%	50 mg
3	Resvenox® (resveratrol >95%)	50 mg
4	Zinc monomethionine (eq. elemental zinc)	10 mg
5	L-selenomethionine (eq. elemental selenium)	40 mcg
6	BioPerine®	3 mg